Investors Capital Advisory Services’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Investors Capital Advisory Services’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,750	Closed	-$169K	–	785
2015 Q2	$169K	Hold	10,750	–	–	0.03%	638
2015 Q1	$116K	Buy	+10,750	New	+$110K	0.02%	662

Other funds holding RPTP

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Investors Capital Advisory Services's RPTP Position: Q3 2015 in Review

Investors Capital Advisory Services sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 10,750 shares — an estimated $169K sold.

Investors Capital Advisory Services first reported a position in RPTP in Q1 2015 and held it in 2 quarters. The position peaked at $169K in Q2 2015. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

Investors Capital Advisory Services reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 10,750 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $169K.
Investors Capital Advisory Services first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2015 and held it in 2 quarters.
Investors Capital Advisory Services's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $169K in Q2 2015.
106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Investors Capital Advisory Services's 13F filing for Q3 2015, filed 17 Nov 2015.